Slowdown mirrors disappointing quarters in refractive, retina, and glaucoma subspecialties due to weather conditions.
Gaming the US tax system has become a major strategy in increasing shareholder value.
Other factors also contribute to depressed demand.
Annual survey indicates that nearly a quarter of responding surgeons plan to buy a new phaco machine within a year.
The company has received CE Marking in Europe for the TECNIS Symfony lens.
Global revenues are expected to increase from roughly $7.9 billion in 2014 to more than 10.4 billion in 2019.
Of the original European countries to which Alimera applied, Italy is the seventh and last to authorize the sustained-release corticosteroid implant for use in DME.
It is the second European country to back reimbursement for off-label use of the cheaper Avastin as a cost-cutting measure.
The Belgium-based company will pursue a potential partnership for commercialization of Jetrea in the US.
The implant delivers the glucocorticosteroid dexamethasone to the posterior segment of the eye.
Combined entity will be renamed New Auxilium.
The Management Board of the European Medicines Agency (EMA) has adopted new rules on publishing clinical trial data.
You are not currently logged in.
©2017 Market Scope
Lost your Password